{
    "clinical_study": {
        "@rank": "134355", 
        "acronym": "NIR", 
        "arm_group": [
            {
                "arm_group_label": "Diabetic neuropathy", 
                "description": "Male participants, type1 diabetic with diabetic neuropathy"
            }, 
            {
                "arm_group_label": "Diabetes without neuropathy", 
                "description": "Male participants, type1 diabetic without diabetic neuropathy"
            }, 
            {
                "arm_group_label": "Non diabetic control", 
                "description": "Male participants, control group non diabetic"
            }
        ], 
        "brief_summary": {
            "textblock": "The aim of the study is to examine the suitability to detect diabetic neuropathy using NIR\n      and impedance."
        }, 
        "brief_title": "NIR- and Multifrequent Impedance Spectroscopy on the Skin in Type 1 Diabetes", 
        "completion_date": {
            "#text": "October 2012", 
            "@type": "Actual"
        }, 
        "condition": "Diabetic Neuropathy", 
        "condition_browse": {
            "mesh_term": [
                "Diabetes Mellitus, Type 1", 
                "Diabetic Neuropathies"
            ]
        }, 
        "detailed_description": {
            "textblock": "The aim of the study is to examine how suitable a hand-held measuring probe (DDD-probe)\n      using NIR (near infrared light) as well as impedance (conductivity), is to detect early\n      signs of diabetic neuropathy.\n\n      The DDD-probe is put directly on the skin and is measuring by the use of light and\n      impedance."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  men with type 1 diabetes (WHO criteria)\n\n          -  age 35-50 years\n\n          -  duration of diabetes > 10 years\n\n        Exclusion Criteria:\n\n          -  P-creatinine> 120 micromol/l\n\n          -  other acute or chronic disease, or type of treatment that makes the patient\n             unsuitable to participate, valuated by the investigator\n\n          -  non intact skin on the measuring spots\n\n          -  the patient is unable to understand the informed consent"
            }, 
            "gender": "Male", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "50 Years", 
            "minimum_age": "35 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Control group men without diabetes Type1 diabetic men without neuropathy complications\n        Type 1 diabetic men with neuropathy complications"
            }
        }, 
        "enrollment": {
            "#text": "30", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "September 25, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01707979", 
            "org_study_id": "NIR"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Near infrared light", 
            "Diabetic neuropathy", 
            "Sensory neuropathy", 
            "Autonomic neuropathy", 
            "Vagus", 
            "Sudomotor function", 
            "Monofilament", 
            "Impedance"
        ], 
        "lastchanged_date": "October 15, 2012", 
        "location": {
            "facility": {
                "address": {
                    "city": "Gentofte", 
                    "country": "Denmark", 
                    "zip": "2820"
                }, 
                "name": "Steno Diabetes Center"
            }
        }, 
        "location_countries": {
            "country": "Denmark"
        }, 
        "number_of_groups": "3", 
        "official_title": "NIR (Near Infrared)- Spectroscopy and Multifrequent Impedance Spectroscopy on the Skin to Detection of Sensory and Autonomic Neuropathy Among Patients With Type 1 Diabetes", 
        "overall_official": {
            "affiliation": "Steno Diabetes Center", 
            "last_name": "Lise Tarnow, Professor", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": [
                "Denmark: Danish Dataprotection Agency", 
                "Denmark: Ethics Committee", 
                "Denmark: The Danish National Committee on Biomedical Research Ethics", 
                "Denmark: Danish Medicines Agency"
            ], 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "October 2012", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Near infrared (NIR) is measured by spectroscopy on the skin using the DDD probe", 
            "measure": "near infrared spectroscopy", 
            "safety_issue": "No", 
            "time_frame": "one time"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01707979"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Steno Diabetes Center", 
            "investigator_full_name": "Lise Tarnow", 
            "investigator_title": "Professor,  Chief Physician", 
            "responsible_party_type": "Sponsor-Investigator"
        }, 
        "source": "Steno Diabetes Center", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Lise Tarnow", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "September 2012", 
        "study_design": "Observational Model: Case Control, Time Perspective: Cross-Sectional", 
        "study_type": "Observational", 
        "verification_date": "October 2012"
    }
}